Search results
Author(s):
Navin K Kapur
Added:
4 years ago
Author(s):
Nicolas M Van Mieghem
Added:
1 year ago
Prof Nicolas Van Mieghem (Thoraxcenter, Erasmus University Medical Center, NL) joins us at EuroPCR to discuss the outcomes of the FORWARD PRO Study (NCT03417011).
FORWARD PRO is a prospective post-market study evaluating the use of the Evolut™ PRO valve (Medtronic) in patients with severe symptomatic aortic stenosis.
Results showed no valve durability issues after 3 years, superior…
View more
Author(s):
Renata Mazurek
Added:
1 year ago
Foreword
Author(s):
Simon Kennon
Added:
3 years ago
Article
Author(s):
Firas Zahr
Added:
2 years ago
In this video interview, Dr Firas Zahr (OHSU Hospital, Portland, OR, US) outlines the 30-day outcomes of the Intrepid TMVR Early Feasibility Study, originally presented at TCT 2021. This was a prospective multicenter trial, designed to study the feasibility of the Intrepid TMVR System. At 30 days, findings show favourable haemodynamics and an improved NYHA class in patients with mitral…
View more
Author(s):
Sebastian Billig
Added:
1 year ago
Author(s):
Pankaj Jain
Added:
3 years ago
Author(s):
Jubin Joseph
,
Tiffany Patterson
,
Satpal Arri
,
et al
Added:
3 years ago
Cardiogenic shock is a clinical condition of inadequate end-organ perfusion due to cardiac dysfunction (see Table 1). It most commonly occurs in the setting of acute MI with left ventricular failure (~80 % cases),1,2 but can also be caused by right ventricular infarction or late mechanical complications, such as acute mitral regurgitation or ventricular rupture (septal or free wall). Non-infarct…
View more
Author(s):
Bart Meyns
Added:
4 years ago
Author(s):
Ralf Westenfeld
Added:
6 years ago